Factors | All (n = 150) | Surgery (n = 73) | Follow-up (n = 77) | p Value | |
---|---|---|---|---|---|
Age | 71.2 | 68.8 | 73.4 | <0.001* | |
Sex | M:F | 128:22 | 66:7 | 62:15 | 0.11 |
Concomitant disease | 22 (14.7%) | 9 (12.3%) | 13 (16.9%) | 0.49 | |
Other cancer | 11 | 5 | 6 | ||
Hematologic disease | 3 | 2 | 1 | ||
Cardiovascular disease | 3 | 2 | 1 | ||
Liver cirrhosis | 5 | 0 | 5 | ||
Positive lymphatic-vascular involvement | 85 (56.7%) | 54 (74.0%) | 31 (40.3%) | <0.001* | |
Undifferenciated type | 19 (12.7%) | 8 (11.0%) | 11 (14.3%) | 0.63 | |
Deep submucosal invasion (≥ sm2) | 96 64.0%) | 56 (76.7%) | 40 (51.9%) | 0.0021* | |
Minute submucosal cancer (sm1 ≥ 30 mm in size) | 9 (6.0%) | 4 (5.5%) | 5 (6.5%) | 1.00 | |
VM positive or unclear | 35 (23.3%) | 12 (16.4%) | 23 (29.9%) | 0.056 | |
HM positive or unclear | 20 (13.3%) | 6 (8.2%) | 14 (18.2%) | 0.093 |